HomeCompareRLYNF vs MRK

RLYNF vs MRK: Dividend Comparison 2026

RLYNF yields 1333.33% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RLYNF wins by $3.50M in total portfolio value
10 years
RLYNF
RLYNF
● Live price
1333.33%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.55M
Annual income
$23,370.23
Full RLYNF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RLYNF vs MRK

📍 RLYNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRLYNFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RLYNF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RLYNF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RLYNF
Annual income on $10K today (after 15% tax)
$113,333.33/yr
After 10yr DRIP, annual income (after tax)
$19,864.70/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RLYNF beats the other by $11,536.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RLYNF + MRK for your $10,000?

RLYNF: 50%MRK: 50%
100% MRK50/50100% RLYNF
Portfolio after 10yr
$1.81M
Annual income
$16,584.19/yr
Blended yield
0.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RLYNF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RLYNF buys
0
MRK buys
0
No recent congressional trades found for RLYNF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRLYNFMRK
Forward yield1333.33%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$3.55M$56.8K
Annual income after 10y$23,370.23$9,798.13
Total dividends collected$2.41M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RLYNF vs MRK ($10,000, DRIP)

YearRLYNF PortfolioRLYNF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$77,367$66,666.67$11,206$366.19+$66.2KRLYNF
2$323,800$241,017.65$12,650$502.35+$311.1KRLYNF
3$817,832$471,365.75$14,407$694.19+$803.4KRLYNF
4$1,431,409$556,328.59$16,585$967.82+$1.41MRLYNF
5$1,986,613$455,006.14$19,342$1,363.89+$1.97MRLYNF
6$2,420,765$295,089.13$22,913$1,947.19+$2.40MRLYNF
7$2,758,246$168,026.89$27,662$2,823.89+$2.73MRLYNF
8$3,040,786$89,463.38$34,159$4,173.35+$3.01MRLYNF
9$3,299,729$46,087.64$43,337$6,308.80+$3.26MRLYNF
10$3,554,080$23,370.23$56,776$9,798.13+$3.50MRLYNF

RLYNF vs MRK: Complete Analysis 2026

RLYNFStock

Rallye SA, together with its subsidiaries, engages in the food and non-food e-commerce retailing business in France and internationally. The company operates in two segments, Food and General Retailing, and Holdings and Other Activities. It operates hypermarkets, supermarkets, and convenience stores. The company conducts its retailing activities in France primarily under the Casino, Monoprix, and Franprix banners; food retail activities in Latin America mainly under the GPA food banners, Éxito, Disco-Devoto, and Libertad banners; and e-commerce comprising Cdiscount and the Cnova N.V. holding company businesses. It is also involved in the financial investment and management, property development, and energy related activities. The company was founded in 1925 and is headquartered in Paris, France. As of December 31, 2021, Rallye SA operates as a subsidiary of Foncière Euris SA.

Full RLYNF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RLYNF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RLYNF vs SCHDRLYNF vs JEPIRLYNF vs ORLYNF vs KORLYNF vs MAINRLYNF vs JNJRLYNF vs ABBVRLYNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.